ValiRx plc (LON:VAL – Get Free Report)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 2 ($0.03) and traded as low as GBX 0.71 ($0.01). ValiRx shares last traded at GBX 0.72 ($0.01), with a volume of 9,620,656 shares traded.
ValiRx Price Performance
The stock has a market capitalization of £943,655.50, a price-to-earnings ratio of -35.65 and a beta of 0.59. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.27 and a current ratio of 6.65. The company has a 50-day moving average of GBX 1.39 and a 200-day moving average of GBX 1.98.
ValiRx Company Profile
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of end-stage non-small cell lung cancer.
See Also
- Five stocks we like better than ValiRx
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 2 Drone Stocks Surging from Increased Media Attention
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
